MediaPress Releases
 September 19, 2014

Sg2 to Speak at Becker’s CEO Strategy Roundtable

Sg2 President and CEO Steve Lefar to discuss how health systems can successfully strategize in the face of a rapidly changing industry

(Skokie, Ill. September 19, 2014) – Sg2, a leader in health care analytics and intelligence, today announced that Steve Lefar, the firm’s president and chief executive officer, will speak at Becker’s Hospital Review Chief Executive Officer Strategy Roundtable.

Lefar’s presentation, “The Game Has Changed. Has Your Strategy?” will take place Wednesday, November 5 from 9:25–10:45 am at the Ritz Carlton Hotel in Chicago, IL. He will discuss how a retail shift, narrow networks, private exchanges, pricing transparency and virtual care are all changing the way that health system leaders must plan for the future.

After joining Sg2 in April 2011, Lefar was promoted to CEO in 2013 with responsibility for all facets of the company. Steve also leads development of the Sg2 Letter (a monthly communication for health care leaders), works directly with CEOs of Sg2’s top clients and oversees new analytics development.

Becker’s Hospital Review Chief Executive Officer Strategy Roundtable brings together hospital and health system executives through high-quality continuing education, networking events, and an exhibit hall highlighting the latest health care services and technologies

What: Becker’s Hospital Review Chief Executive Officer Strategy Roundtable
When: Wednesday, November 5, 2014, from 9:25–10:45 am
Who: Sg2 President and CEO Steve Lefar
Where: Ritz Carlton Hotel, Chicago, IL

 

To learn more about Sg2 or to setup a time to speak with Steve Lefar, please email pschuerer@sg2.com.

About Sg2
Sg2’s analytics-based health care expertise helps hospitals and health systems integrate, prioritize and drive growth and performance across the continuum of care. Over 1200 organizations around the world rely on Sg2’s analytics, intelligence, consulting and educational services.

  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Facebook Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube